80
Participants
Start Date
August 16, 2017
Primary Completion Date
November 17, 2021
Study Completion Date
May 21, 2022
Intra uterine infusion of platelet rich plasma
Platelet Rich Plasma (PRP) is a blood product with a high platelet and a normal plasma fibrinogen level. Given the effective factors of RPR in repairing damaged tissues, its application in the field of regenerative medicine has widely been interested over the last three decades. According to the literature, PRP is an effective and safe treatment in the fields of orthopaedics, dermatology, ophthalmology, and repair of neurological, vascular, and connective tissue damage, but its application in the field of infertility is limited to a few pilot studies in which the effects of PRP on endometrium and recurrent implantation failure (RIF) were investigated.
Royan Institute, Tehran
Royan Institute
OTHER_GOV